FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385264246> ?p ?o ?g. }

• W4385264246 endingPage "871" @default.
• W4385264246 startingPage "871" @default.
• W4385264246 abstract "Importance Inadequate representation of older patients, women, and racial minority individuals in cardiovascular clinical trials limits both the generalizability of trial findings and inclusivity in access to novel therapies and therapeutic strategies. Objective To report on temporal trends in the representation of older patients, women, and racial and ethnic minority individuals in clinical trials studying treatments for valvular heart disease. Evidence Review All published clinical trials enrolling more than 100 adults with any valvular heart disease published between 2005 and 2020 were included after searches with PubMed and ClinicalTrials.gov. Data on age, sex, race, and ethnicity reported in the included studies were collected. Trials were assigned to 4 time periods based on the publication date, and temporal trends were analyzed in the representation of older patients, women, and racial and ethnic minority individuals. Findings A total of 139 clinical trials with 51 527 participants were identified. Of these trials, 103 (74%) investigated aortic valve disease and the remainder mitral valve disease. Overall, 63 trials (45.3%) enrolled patients only in Europe, 24 (17.3%) only in North America, and 19 (13.7%) in multiple geographical regions. The weighted mean (SD) age of enrolled patients was 68.4 (11.4) years, increasing nonsignificantly from 61.9 (5.9) years in 2005-2008 to 72.8 (9.6) years in 2017-2020 ( P = .09 for trend). The overall proportion of women enrolled in valvular heart disease trials was 41.1%, with no significant changes over time. Data on race and ethnicity of trial participants were reported in 13 trials (9.4%), in which trial-level representation of American Indian/Alaska Native, Asian, Black/African American, Hispanic, and Native Hawaiian/Pacific Islander patients ranged from 0.27% to 43.9%. There were no significant temporal trends noted in the enrollment of racial and ethnic minority populations. The representation of women in clinical trials was positively associated with enrollment rates of older patients and underrepresented racial and ethnic groups. Conclusions and Relevance This review found that over the past 2 decades, women and racial and ethnic minority individuals have remained underrepresented in North American valvular heart disease clinical trials. Further work is needed to improve the reporting of race and ethnicity data and address barriers to trial enrollment for older patients, women, and racial and ethnic minority individuals." @default.
• W4385264246 created "2023-07-27" @default.
• W4385264246 creator A5000203028 @default.
• W4385264246 creator A5011459557 @default.
• W4385264246 creator A5016139987 @default.
• W4385264246 creator A5017112672 @default.
• W4385264246 creator A5043374949 @default.
• W4385264246 creator A5052324988 @default.
• W4385264246 creator A5055901098 @default.
• W4385264246 creator A5057100644 @default.
• W4385264246 creator A5058311555 @default.
• W4385264246 creator A5074361601 @default.
• W4385264246 creator A5079070292 @default.
• W4385264246 creator A5086598653 @default.
• W4385264246 date "2023-09-01" @default.
• W4385264246 modified "2023-10-16" @default.
• W4385264246 title "Enrollment of Older Patients, Women, and Racial and Ethnic Minority Individuals in Valvular Heart Disease Clinical Trials" @default.
• W4385264246 cites W1971274277 @default.
• W4385264246 cites W2027795935 @default.
• W4385264246 cites W2040262898 @default.
• W4385264246 cites W2042572308 @default.
• W4385264246 cites W2049813862 @default.
• W4385264246 cites W2130378535 @default.
• W4385264246 cites W2153003445 @default.
• W4385264246 cites W2189916683 @default.
• W4385264246 cites W2206259485 @default.
• W4385264246 cites W2219329093 @default.
• W4385264246 cites W2300698937 @default.
• W4385264246 cites W2315376359 @default.
• W4385264246 cites W2325781243 @default.
• W4385264246 cites W2792841583 @default.
• W4385264246 cites W2800815486 @default.
• W4385264246 cites W2888524010 @default.
• W4385264246 cites W2889465019 @default.
• W4385264246 cites W2896634370 @default.
• W4385264246 cites W2945559059 @default.
• W4385264246 cites W2998272399 @default.
• W4385264246 cites W3013424499 @default.
• W4385264246 cites W3027621731 @default.
• W4385264246 cites W3028084243 @default.
• W4385264246 cites W3029060449 @default.
• W4385264246 cites W3095673845 @default.
• W4385264246 cites W3191480438 @default.
• W4385264246 cites W3210596029 @default.
• W4385264246 cites W3215417855 @default.
• W4385264246 cites W4200496290 @default.
• W4385264246 cites W4210537426 @default.
• W4385264246 cites W4213091955 @default.
• W4385264246 cites W4220841869 @default.
• W4385264246 cites W4237842933 @default.
• W4385264246 cites W4303646155 @default.
• W4385264246 cites W4310462858 @default.
• W4385264246 cites W4310957609 @default.
• W4385264246 cites W4321112078 @default.
• W4385264246 doi "https://doi.org/10.1001/jamacardio.2023.2098" @default.
• W4385264246 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37494015" @default.
• W4385264246 hasPublicationYear "2023" @default.
• W4385264246 type Work @default.
• W4385264246 citedByCount "2" @default.
• W4385264246 countsByYear W43852642462023 @default.
• W4385264246 crossrefType "journal-article" @default.
• W4385264246 hasAuthorship W4385264246A5000203028 @default.
• W4385264246 hasAuthorship W4385264246A5011459557 @default.
• W4385264246 hasAuthorship W4385264246A5016139987 @default.
• W4385264246 hasAuthorship W4385264246A5017112672 @default.
• W4385264246 hasAuthorship W4385264246A5043374949 @default.
• W4385264246 hasAuthorship W4385264246A5052324988 @default.
• W4385264246 hasAuthorship W4385264246A5055901098 @default.
• W4385264246 hasAuthorship W4385264246A5057100644 @default.
• W4385264246 hasAuthorship W4385264246A5058311555 @default.
• W4385264246 hasAuthorship W4385264246A5074361601 @default.
• W4385264246 hasAuthorship W4385264246A5079070292 @default.
• W4385264246 hasAuthorship W4385264246A5086598653 @default.
• W4385264246 hasConcept C105795698 @default.
• W4385264246 hasConcept C126322002 @default.
• W4385264246 hasConcept C137403100 @default.
• W4385264246 hasConcept C144024400 @default.
• W4385264246 hasConcept C149923435 @default.
• W4385264246 hasConcept C1862650 @default.
• W4385264246 hasConcept C19165224 @default.
• W4385264246 hasConcept C27158222 @default.
• W4385264246 hasConcept C2779134260 @default.
• W4385264246 hasConcept C2779736815 @default.
• W4385264246 hasConcept C33923547 @default.
• W4385264246 hasConcept C535046627 @default.
• W4385264246 hasConcept C71924100 @default.
• W4385264246 hasConcept C74909509 @default.
• W4385264246 hasConceptScore W4385264246C105795698 @default.
• W4385264246 hasConceptScore W4385264246C126322002 @default.
• W4385264246 hasConceptScore W4385264246C137403100 @default.
• W4385264246 hasConceptScore W4385264246C144024400 @default.
• W4385264246 hasConceptScore W4385264246C149923435 @default.
• W4385264246 hasConceptScore W4385264246C1862650 @default.
• W4385264246 hasConceptScore W4385264246C19165224 @default.
• W4385264246 hasConceptScore W4385264246C27158222 @default.
• W4385264246 hasConceptScore W4385264246C2779134260 @default.
• W4385264246 hasConceptScore W4385264246C2779736815 @default.
• W4385264246 hasConceptScore W4385264246C33923547 @default.

• next